drugset / Trial / NCT02772640

Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe

NCT02772640

Phase 4 Completed 83 enrolled Collegium Medicum w Bydgoszczy
RandomizedCrossoverOpen-labelTreatment

Summary

The aim of the study is to demonstrate, whether the time of day of administration of the study drug (containing rosuvastatin and ezetimibe) has an impact on the effectiveness of lipid-lowering therapy.

Timeline

Start
2016-03
Primary completion
2019-01
Completion
2020-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ezetimibe Unknown
Comparator Rosuvastatin Small molecule

Indications